These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22237583)

  • 1. Extracellular matrix alterations in the atria: insights into the mechanisms and perpetuation of atrial fibrillation.
    Goudis CA; Kallergis EM; Vardas PE
    Europace; 2012 May; 14(5):623-30. PubMed ID: 22237583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and Cellular Mechanisms of Atrial Fibrosis in Atrial Fibrillation.
    Nattel S
    JACC Clin Electrophysiol; 2017 May; 3(5):425-435. PubMed ID: 29759598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation.
    Burstein B; Nattel S
    J Am Coll Cardiol; 2008 Feb; 51(8):802-9. PubMed ID: 18294563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of persistent atrial fibrillation.
    Jalife J
    Curr Opin Cardiol; 2014 Jan; 29(1):20-7. PubMed ID: 24281345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fibrosis and atrial fibrillation: is the transforming growth factor-beta 1 a candidate etiology of atrial fibrillation.
    Li X; Ma C; Dong J; Liu X; Long D; Tian Y; Yu R
    Med Hypotheses; 2008; 70(2):317-9. PubMed ID: 17689021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma transforming growth factor beta1 as a biochemical marker to predict the persistence of atrial fibrillation after the surgical maze procedure.
    On YK; Jeon ES; Lee SY; Shin DH; Choi JO; Sung J; Kim JS; Sung K; Park P
    J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1515-20. PubMed ID: 19464473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrial fibrillation and atrial fibrosis.
    Tan AY; Zimetbaum P
    J Cardiovasc Pharmacol; 2011 Jun; 57(6):625-9. PubMed ID: 21633248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.
    Anné W; Willems R; Roskams T; Sergeant P; Herijgers P; Holemans P; Ector H; Heidbüchel H
    Cardiovasc Res; 2005 Sep; 67(4):655-66. PubMed ID: 15913581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Biology of the substrate of atrial fibrillation].
    Hatem S
    Biol Aujourdhui; 2012; 206(1):5-9. PubMed ID: 22463991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase-9/tissue inhibitors of metalloproteinase-1 expression and atrial structural remodeling in a dog model of atrial fibrillation: inhibition with angiotensin-converting enzyme.
    Zhang W; Zhong M; Yang GR; Li JP; Guo C; Wang Z; Zhang Y
    Cardiovasc Pathol; 2008; 17(6):399-409. PubMed ID: 18706834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of imaging in assessment of atrial fibrosis in patients with atrial fibrillation: state-of-the-art review.
    Longobardo L; Todaro MC; Zito C; Piccione MC; Di Bella G; Oreto L; Khandheria BK; Carerj S
    Eur Heart J Cardiovasc Imaging; 2014 Jan; 15(1):1-5. PubMed ID: 23798579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation.
    Chen CL; Huang SK; Lin JL; Lai LP; Lai SC; Liu CW; Chen WC; Wen CH; Lin CS
    J Mol Cell Cardiol; 2008 Dec; 45(6):742-53. PubMed ID: 18692064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation.
    De Jong AM; Maass AH; Oberdorf-Maass SU; Van Veldhuisen DJ; Van Gilst WH; Van Gelder IC
    Cardiovasc Res; 2011 Mar; 89(4):754-65. PubMed ID: 21075756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic fibrogenesis: the puzzle of interacting cells, fibrogenic cytokines, regulatory loops, and extracellular matrix molecules.
    Gressner AM
    Z Gastroenterol; 1992 Mar; 30 Suppl 1():5-16. PubMed ID: 1449018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Morphological remodeling in atrial fibrillation].
    Goette A; Lendeckel U
    Herz; 2006 Apr; 31(2):101-7; quiz 142-3. PubMed ID: 16738831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial remodeling in atrial fibrillation and some related microRNAs.
    Sharma D; Li G; Xu G; Liu Y; Xu Y
    Cardiology; 2011; 120(2):111-21. PubMed ID: 22179059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electrophysiological remodeling induced by atrial fibrillation. An experimental curiosity or major factor in atrial fibrillation in man?].
    Piot O; Paziaud O; Digeos S; Copie X; Lavergne T; Guize L; Le Heuzey JY
    Arch Mal Coeur Vaiss; 2000 Jul; 93(7):841-8. PubMed ID: 10975036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation: a progressive atrial myopathy or a distinct disease?
    Kallergis EM; Goudis CA; Vardas PE
    Int J Cardiol; 2014 Feb; 171(2):126-33. PubMed ID: 24388634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of atrial remodeling and clinical relevance.
    Nattel S; Shiroshita-Takeshita A; Cardin S; Pelletier P
    Curr Opin Cardiol; 2005 Jan; 20(1):21-5. PubMed ID: 15596955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular matrix alterations in patients with paroxysmal and persistent atrial fibrillation: biochemical assessment of collagen type-I turnover.
    Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Arfanakis DA; Maliaraki NE; Lathourakis CE; Chlouverakis GI; Vardas PE
    J Am Coll Cardiol; 2008 Jul; 52(3):211-5. PubMed ID: 18617070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.